NASDAQ: IVDA

Iveda Solutions, Inc.

CIK 0001397183 · SIC 7372 · Prepackaged Software

Micro Revenue $5M Assets $7M as of Nov 21, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (JEF 10-Q) is open in full — no account needed.

424B5 Filed Nov 20, 2026

Summary not yet generated.

10-Q Filed Nov 16, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

Partner

Trade IVDA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Sep 9, 2026 · Period ending Sep 4, 2026

Summary not yet generated.

10-Q Filed Aug 14, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

424B3 Filed Apr 2, 2026

Summary not yet generated.

424B3 Filed Apr 2, 2026

Summary not yet generated.

424B3 Filed Apr 2, 2026

Summary not yet generated.

10-K Filed Mar 31, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

8-K Filed Mar 6, 2026 · Period ending Mar 6, 2026

Summary not yet generated.

8-K Filed Feb 13, 2026 · Period ending Feb 9, 2026

Summary not yet generated.

424B4 Filed Feb 11, 2026

Summary not yet generated.

S-1/A Filed Feb 4, 2026

Summary not yet generated.

S-1 Filed Feb 2, 2026

Summary not yet generated.

10-K/A Filed Jun 16, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

10-K Filed Apr 15, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B5 Filed Feb 27, 2025

Summary not yet generated.

424B5 Filed Sep 6, 2024

Summary not yet generated.

S-1 Filed Aug 23, 2022

Summary not yet generated.

S-1/A Filed Mar 28, 2022

Summary not yet generated.

S-1/A Filed Mar 15, 2022

Summary not yet generated.

S-1 Filed Dec 30, 2021

Summary not yet generated.

424B4 Filed May 13, 2015

Summary not yet generated.

10-Q/A Filed Mar 7, 2012 · Period ending Jun 30, 2011

Summary not yet generated.

Latest financial statements

From 10-Q filed Nov 16, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
REVENUE
Equipment Sales 1,501,983 1,522,776 3,644,566 4,380,506
Service Revenue 121,400 129,011 274,837 273,764
TOTAL REVENUE 1,623,383 1,651,787 3,919,403 4,654,270
COST OF REVENUE 1,045,163 1,134,510 2,407,413 3,404,012
GROSS PROFIT 578,220 517,277 1,511,990 1,250,258
OPERATING EXPENSES
General & Administrative 1,326,050 705,830 3,407,876 2,722,229
Research & Development 53,738 25,750 181,507 110,250
Total Operating Expenses 1,379,788 731,580 3,589,383 2,832,479
LOSS FROM OPERATIONS (801,568) (214,303) (2,077,393) (1,582,221)
OTHER INCOME (EXPENSE)
Miscellaneous Income (Expense) 1,525 (22) 12,006 32,125
Interest Income 29,297 5,260 94,359 30,801
Interest Expense (7,411) (11,574) (19,333) (29,487)
Total Other Income (Expense), Net 23,411 (6,336) 87,032 33,439
LOSS BEFORE INCOME TAXES (778,157) (220,639) (1,990,361) (1,548,782)
PROVISION FOR INCOME TAXES (70,696) (665) (184,792) (30,443)
NET LOSS (848,853) (221,304) (2,175,153) (1,579,225)
BASIC AND DILUTED LOSS PER SHARE (0.07) (0.07) (0.19) (0.54)
WEIGHTED AVERAGE SHARES 12,948,162 3,045,753 11,265,827 2,897,887

Condensed Consolidated Balance Sheets

Description September 30, 2026 (UNAUDITED) December 31, 2025
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents 3,880,414 5,156,252
Restricted Cash 62,825 63,694
Accounts Receivable, Net 586,786 256,699
Deferred Cost of Goods 1,491,443 116,951
Inventory, Net 226,285 235,958
Other Current Assets 281,325 326,005
Total Current Assets 6,529,078 6,155,559
Property and Equipment, Net 55,901 47,093
Right of Use Asset, Net 116,815 148,943
Other Assets 189,597 76,195
Total Assets 6,891,391 6,427,790
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts and Other Payables 746,379 938,560
Short Term Debt 627,313 159,500
Current Portion of Long-Term Debt 171,466 127,600
Current Portion of Lease Liability 45,384 41,632
Total Current Liabilities 1,590,542 1,267,292
Long Term Debt 372,205 265,832
Long Term Lease Liability, Net of Current Portion 81,227 114,904
Total Liabilities 2,043,974 1,648,028
STOCKHOLDERS’ EQUITY
Preferred Stock, $0.00001 par value; 12,500,000 shares authorized, no preferred shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively - -
Common Stock, $0.00001 par value; 300,000,000 shares authorized; 13,354,739 and 5,879,741 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 134 59
Additional Paid-In Capital 63,663,671 61,403,700
Accumulated Other Comprehensive Loss (266,406) (249,168)
Accumulated Deficit (58,549,982) (56,374,829)
Total Stockholders’ Equity 4,847,417 4,779,762
Total Liabilities and Stockholders’ Equity 6,891,391 6,427,790

Condensed Consolidated Statements of Cash Flows (Unaudited)

Description September 30, 2026 September 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss (2,175,153) (1,579,225)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Depreciation and Amortization 17,220 16,062
Stock Compensation Expense 12,000 -
Stock Issued for Services 58,000 67,500
Changes in operating assets and liabilities
Accounts Receivable (330,087) (46,451)
Inventory 9,673 (99,396)
Deferred Cost of Goods (1,374,492) 269,559
Right of Use Asset 32,128 23,405
Other Current Assets 44,679 96,950
Other Assets (113,402) (272)
Increase in Accounts and Other Payables (192,181) (507,956)
Lease Liability (29,925) (15,256)
Net Cash Used in Operating Activities (4,041,540) (1,775,080)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Property and Equipment (26,090) -
Net Cash Used in Investing Activities (26,090) -
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on Short-Term Debt (341,119) (335,520)
Proceeds from Short-Term Debt 852,798 72,629
Payments on Long-Term Debt (63,824) (60,506)
Proceeds from Long-Term Debt 170,197 -
Common Stock Issued, Net of Cost of Financing 2,190,046 2,706,346
Net Cash Provided by Financing Activities 2,808,098 2,382,949
EFFECT OF EXCHANGE RATE CHANGES ON CASH (17,175) 65,107
NET DECREASE IN CASH, RESTRICTED CASH AND CASH EQUIVALENTS (1,276,707) 672,976
Cash, Restricted Cash and Cash Equivalents- Beginning of Period 5,219,946 2,658,300
CASH, RESTRICTED CASH AND CASH EQUIVALENTS END OF PERIOD 3,943,239 3,331,276

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗